283 results
-
List item
Withdrawn application: Pioglitazone ratiopharm
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm: Withdrawn application … authorisation) Pioglitazone ratiopharm pioglitazone On 21 July … medicinal product Pioglitazone ratiopharm 15, 30, 45 mg tablet intended … -
List item
Withdrawn application: Pioglitazone ratiopharm GmbH
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm GmbH: Withdrawn application … authorisation) Pioglitazone ratiopharm GmbH pioglitazone On 21 … medicinal product Pioglitazone ratiopharm GmbH 15, 30, 45 mg tablet … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm
levetiracetam, Epilepsy
Date of authorisation: 26/08/2011,
, Revision: 12, Authorised, Last updated: 22/06/2021
Levetiracetam ratiopharm Epilepsy … EPAR) for Levetiracetam ratiopharm. It explains how the Committee … of use for Levetiracetam ratiopharm. What is Levetiracetam ratiopharm? Levetiracetam ratiopharm is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Desloratadine ratiopharm
desloratadine, Rhinitis, Allergic, Perennial, Urticaria, Rhinitis, Allergic, Seasonal
Date of authorisation: 13/01/2012,, Revision: 9, Authorised, Last updated: 03/02/2021
Desloratadine ratiopharm Rhinitis, Allergic, Perennial Urticaria Rhinitis … desloratadine Overview Desloratadine ratiopharm is a medicine used in adults … is unknown. Desloratadine ratiopharm contains the active substance … -
List item
Human medicine European public assessment report (EPAR): Rasagiline ratiopharm
rasagiline, Parkinson Disease
Date of authorisation: 12/01/2015, Revision: 7, Authorised, Last updated: 22/10/2020Rasagiline ratiopharm Parkinson Disease … report (EPAR) for Rasagiline ratiopharm. It explains how the Agency … on how to use Rasagiline ratiopharm. For practical information … -
List item
Human medicine European public assessment report (EPAR): Sildenafil ratiopharm
sildenafil, Erectile Dysfunction
Date of authorisation: 23/12/2009,, Revision: 17, Authorised, Last updated: 06/10/2020
Sildenafil ratiopharm Erectile Dysfunction … sildenafil. What is Sildenafil ratiopharm? Sildenafil ratiopharm is a medicine that contains … 50 and 100 mg). Sildenafil ratiopharm is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Leflunomide ratiopharm
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 28/11/2010,, Revision: 14, Authorised, Last updated: 11/09/2020
Leflunomide ratiopharm Arthritis, Rheumatoid … report (EPAR) for Leflunomide ratiopharm. It explains how the Committee … conditions of use for Leflunomide ratiopharm. What is Leflunomide ratiopharm? Leflunomide ratiopharm is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel, Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009,, Revision: 5, Withdrawn, Last updated: 12/12/2013
Clopidogrel ratiopharm Peripheral Vascular Diseases Stroke Myocardial … authorisation for Clopidogrel ratiopharm has been withdrawn at the … Summary documents Clopidogrel ratiopharm : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Filgrastim ratiopharm
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,
, Revision: 1, Withdrawn, Last updated: 20/07/2011
Filgrastim ratiopharm Neutropenia Hematopoietic … Filgrastim ratiopharm … Filgrastim ratiopharm, INN-filgrastim 7 Westferry … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm GmbH
clopidogrel, Peripheral Vascular Diseases, Acute Coronary Syndrome, Myocardial Infarction, Stroke
Date of authorisation: 28/07/2009,, Revision: 12, Withdrawn, Last updated: 25/01/2021
Clopidogrel ratiopharm GmbH Peripheral Vascular … authorisation for Clopidogrel Ratiopharm GmbH has been withdrawn at … Summary documents Clopidogrel ratiopharm GmbH : EPAR - Summary for … -
List item
Human medicine European public assessment report (EPAR): Memantine ratiopharm
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 12/06/2013,, Revision: 6, Authorised, Last updated: 15/08/2018
Memantine ratiopharm Alzheimer Disease … report (EPAR) for Memantine ratiopharm. It explains how the European … advice on how to use Memantine ratiopharm. For practical information … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm
clopidogrel (as hydrogen sulfate), Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015,, Revision: 11, Authorised, Last updated: 10/06/2021
Clopidogrel ratiopharm Myocardial Infarction Acute … report (EPAR) for Clopidogrel ratiopharm. It explains how the Agency … on how to use Clopidogrel ratiopharm. For practical information … -
List item
Referral: Trimetadizine ratiopharm
trimetazidine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/01/2009, EC decision date: 19/03/2009, Last updated: 22/01/2009Trimetadizine ratiopharm … not known. Trimetazidine Ratiopharm is a generic medicine based … Trimetadizine-ratiopharm reviewed? ratiopharm GmbH submitted Trimetazidine-ratiopharm … -
List item
Referral: Valproat Ratiopharm Chrono
valproic acid, valproate, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 25/05/2010, EC decision date: 26/05/2010, Last updated: 23/07/2012Valproat Ratiopharm Chrono … company that markets Valproat Ratiopharm Chrono, a generic medicine … medicines, including Valproat Ratiopharm Chrono. Because bipolar disorder … -
List item
Referral: Fentanyl-ratiopharm Matrixpflaster
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007only with opioid analgesics. Ratiopharm GmbH submitted applications … with opioid analgesics. Ratiopharm GmbH submitted applications … favourable for Fentanyl- ratiopharm 25/50/75/100 µg/h Matrixpflaster … -
List item
Referral: Fentanyl-ratiopharm_TTS
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007only with opioid analgesics. Ratiopharm GmbH submitted applications … with opioid analgesics. Ratiopharm GmbH submitted applications … favourable for Fentanyl- ratiopharm 25/50/75/100 µg/h TTS and … -
List item
Referral: Lansoprazol-ratiopharm 15 mg and 30 mg
Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 21/02/2006, Last updated: 25/02/2006was previously granted to ratiopharm GmbH in Finland on 7 November … was previously granted to ratiopharm GmbH in Finland on 7 November … administration Lansoprazol "ratiopharm" 15 mg Kapseln 15 mg Gastro-resistant … -
List item
Human medicine European public assessment report (EPAR): Ratiograstim
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,, Revision: 12, Authorised, Last updated: 19/10/2020
the EU for Ratiograstim to ratiopharm GmbH on 15 September 2008 … -
List item
Human medicine European public assessment report (EPAR): Pazenir
paclitaxel, Breast Neoplasms
Date of authorisation: 06/05/2019,, Revision: 6, Authorised, Last updated: 25/05/2021
-
List item
National expert: Constanze Freiler, Austrian Medicines and Medical Devices Agency (updated)
- Declaration of interests - 80.27 KB | PDF
- Curriculum Vitae - 17.7 KB | PDF
Manager Pharmacovigilance TEVA ratiopharm, Vienna (Austria) Head of … Indication 04/2013-08/2018 TEVA ratiopharm Cross product responsibility … -
List item
Human medicine European public assessment report (EPAR): Eporatio
epoetin theta, Kidney Failure, Chronic, Anemia, Cancer
Date of authorisation: 29/10/2009, Revision: 11, Authorised, Last updated: 13/06/2018European Union for Eporatio to ratiopharm GmbH on 29 October 2009 … European Union for Eporatio to ratiopharm GmbH on 29 October 2009 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): epoetin theta
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Haematology-Hemostaseology
PIP number: Epoetin theta, Route(s) of administration: Intravenous use, Subcutaneous use, Pharmaceutical form(s): Solution for injection
Decision date: 20/07/2008, Last updated: 08/09/2008, Compliance check: XIntravenous use Subcutaneous use Ratiopharm GmbH E-mail: info ratiopharm.de Country: Germany Phone … application submitted by Ratiopharm GmbH on 6 March 2008 under … decision is addressed to Ratiopharm GmbH, Graf-Arco-Strasse 3 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): epoetin theta
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Haematology-Hemostaseology
PIP number: Epoetin theta, Route(s) of administration: Intravenous use, Subcutaneous use, Pharmaceutical form(s): Solution for injection
Decision date: 20/07/2008, Last updated: 08/09/2008, Compliance check: XIntravenous use Subcutaneous use Ratiopharm GmbH E-mail: info ratiopharm.de Country: Germany Phone … application submitted by Ratiopharm GmbH on 6 March 2008 under … decision is addressed to Ratiopharm GmbH, Graf-Arco-Strasse 3 … -
List item
Press release: European Medicines Agency recommends precautionary recall of batches of clopidogrel-containing medicines from Acino Pharma GmbH
Last updated: 25/03/2010Clopidogrel Hexal, Clopidogrel Ratiopharm, Clopidogrel Ratiopharm GmbH and Clopidogrel Sandoz … Clopidogrel Hexal: EPAR Clopidogrel ratiopharm: EPAR Clopidogrel ratiopharm GmbH: EPAR Clopidogrel Sandoz … Clopidogrel Hexal, Clopidogrel Ratiopharm, Clopidogrel Ratiopharm GmbH and Clopidogrel Sandoz … -
List item
National expert: Harriet Palissa, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 80.32 KB | PDF
- Curriculum Vitae - 18.59 KB | PDF
Excecutive Senior Management Award Ratiopharm GmbH (Germany) June 1984-May …